Intravoxel incoherent motion imaging for diagnosing and staging the liver fibrosis and inflammation
To evaluate the diagnostic accuracy of intravoxel incoherent motion (IVIM) model parameters for the diagnosis and staging of liver fibrosis and inflammation in patients with chronic hepatitis B.
Fifty-four patients with chronic hepatitis B and 42 healthy volunteers were included in the study. All subjects were examined by 3 T magnetic resonance imaging. Diffusion-weighted imaging was undertaken with sixteen b values. IVIM parameters [D (true diffusion coefficient), D* (pseudo-diffusion coefficient), f (perfusion fraction)] were calculated. Histological evaluation of biopsy samples was considered the reference standard for the staging of liver fibrosis and inflammation. Differences in IVIM parameters between patient and control groups were analyzed. In the patient group, fibrosis stage and inflammation grade groups were analyzed with respect to IVIM parameters. The correlation was assessed between IVIM parameters and Ishak-modified scale of fibrosis stages and inflammation grades.
The D was significantly lower in the patient group than the control group, p = 0.038 with Cohen’s d effect size of 0.452. D was significantly different between fibrosis stage levels. D values decreased in fibrosis stages from the minimal to moderate to marked fibrosis. Fibrosis grades significantly negatively correlated with D and D* values, p = 0.001, and 0.021, respectively. In addition, inflammation grades negatively correlated with f values, p = 0.047.
D values measured with IVIM imaging may help to diagnose liver fibrosis. IVIM imaging could be an alternative to liver biopsy for the staging of liver fibrosis.
KeywordsChronic hepatitis Intravoxel incoherent motion Fibrosis stage Inflammation grade
MT: concept, acquisition of data, literature review, manuscript draft, revision, final approval. TO: acquisition of data, data analysis, literature review, manuscript draft, editing, final approval. HU: acquisition of data, literature review, final approval. BA: acquisition of data, literature review, final approval. SA: clinical care of patients, literature review, final approval.
The authors declared that this study has received no financial support.
Compliance with ethical standards
Conflict of interest
No conflict of interest was declared by the authors.
- 4.Shayesteh M, Shayesteh AA, Motamedfar A, Tahmasebi M, Bagheri S et al. The clinical value of the apparent diffusion coefficient of liver magnetic resonance images in patients with liver fibrosis compared to healthy subjects. J Family Med Prim Care. 2018;7(6):1501-1505. https://doi.org/10.4103/jfmpc.jfmpc_299_18.CrossRefGoogle Scholar
- 7.Tapper EB, Lok ASF. Use of Liver Imaging and Biopsy in Clinical Practice. N Engl J Med 2017; 377: 2296-2297 [PMID: 29211669 https://doi.org/10.1056/nejmc1712445]
- 14.Li T, Che-Nordin N, Wáng YXJ, Rong PF, Qiu SW. Intravoxel incoherent motion derived liver perfusion/diffusion readouts can be reliable biomarker for the detection of viral hepatitis B induced liver fibrosis. Quant Imaging Med Surg. 2019;9(3):371-385. https://doi.org/10.21037/qims.2019.02.11.CrossRefGoogle Scholar
- 15.Wu CH, Ho MC, Jeng YM, Liang PC, Hu RH, Lai HS, et al. Assessing hepatic fibrosis: comparing the intravoxel incoherent motion in MRI with acoustic radiation force impulse imaging in US. Eur Radiol. 2015; 25:3552–9. https://doi.org/10.1007/s00330-015-3774-4 PMID: 25991478.CrossRefPubMedGoogle Scholar
- 24.Wáng YX, Li YT, Chevallier O, Huang H, Leung JCS, et al. Dependence of intravoxel incoherent motion diffusion MR threshold b-value selection for separating perfusion and diffusion compartments and liver fibrosis diagnostic performance. Acta Radiol. 2019; 60:3-12. https://doi.org/10.1177/0284185118774913.CrossRefPubMedGoogle Scholar
- 27.Andreou A, Koh DM, Collins DJ,Blackledge M, Wallace T, et al. Measurement reproducibility of perfusion fraction and pseudodiffusion coefficient derived by intravoxel incoherent motion diffusion-weighted MR imaging in normal liver and metastases. Eur Radiol. 2013; 23:428–434. https://doi.org/10.1007/s00330-012-2604-1.CrossRefPubMedGoogle Scholar
- 33.Anderson SW, Jara H, Ozonoff A, O’Brien M, Hamilton JA,et al. Effect of disease progression on liver apparent diffusion coefficient and T2 values in a murine model of hepatic fibrosis at 11.7 Tesla MRI, J. Magn. Reson. Imaging. 2012;35(1): 140–146. https://doi.org/10.1002/jmri.22807.CrossRefGoogle Scholar
- 36.França M, Martí-Bonmatí L, Alberich-Bayarri Á, Oliveira P, Guimaraes S, et al. Evaluation of fibrosis and inflammation in diffuse liver diseases using intravoxel incoherent motion diffusion-weighted MR imaging. Abdom Radiol (NY). 2017; 42 (2):468-477. https://doi.org/10.1007/s00261-016-0899-0.CrossRefPubMedGoogle Scholar
- 38.Dyvorne HA1, Galea N, Nevers T, Fiel MI, Carpenter D, et al. Diffusion-weighted imaging of the liver with multiple b values: effect of diffusion gradient polarity and breathing acquisition on image quality and intravoxel incoherent motion parameters-A pilot study. Radiology. 2013; 266(3):920-9. https://doi.org/10.1148/radiol.12120686.CrossRefGoogle Scholar
- 43.Zhu J, Zhang J, Gao J, Li JN, Yang DW, et al. Apparent diffusion coefficient normalization of normal liver: Will it improve the reproducibility of diffusion-weighted imaging at different MR scanners as a new biomarker? Medicine (Baltimore). 2017; 96:3: e5910. https://doi.org/10.1097/md.0000000000005910.CrossRefPubMedPubMedCentralGoogle Scholar
- 46.Ichikawa S, Motosugi U, Morisaka H, Sano K, Ichikawa T, Enomoto N, et al. MRI-Based Staging of Hepatic Fibrosis: Comparison of Intravoxel Incoherent Motion Difusion-Weighted Imaging with Magnetic Resonance Elastography. J Magn Reson Imaging. 2015;42(1):204-210. https://doi.org/10.1002/jmri.24760.CrossRefPubMedGoogle Scholar